Dillan DiNardo: Mindstate Design Labs
Mycopreneur
00:00
Navigating the Intersection of FDA Regulation and Decentralized Psychedelic Use
The chapter explores the balance between FDA regulation and decentralized psychedelic use, emphasizing the value of both approaches in advancing psychedelic research and therapy. The guest discusses their journey from finance to biotech venture capital, sharing insights on the evolution of their psychedelic awareness and the founding of Mind State Design Labs. The conversation touches on the role of AI in drug development, the effects of diverse psychedelic compounds on consciousness, and the challenges and potential of novel molecules like Moxys in altering states of consciousness.
Transcript
Play full episode
